Wyeth Deals Signal Diversification Strategy
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 1 (Table of Contents)
Published: 12 Jan-2009
DOI: 10.3833/pdr.v2009.i1.89 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Wyeth and Santaris have entered into an agreement to develop new drugs based on Santaris’ Locked Nucleic Acid drug platform that could treat protein-related diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS